Journals By Industry - Cardiovascular Drugs

In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease, or CKD, and major vascular events were reduced in the treatment group compared to placebo. The...

Results from the trial, expected in 2014, could potentially impact atrial fibrillation treatment guidelines by providing further clinical evidence regarding the benefits of the Arctic Front system in treating a largely underserved patient...

The settlement also includes APP's agreement to dismiss its appeal of the August 2010 federal district court decision holding that MDCO's application for Hatch Waxman patent term extension of the Angiomax composition of...

The Medicines Company (MDCO) has settled the lawsuits filed in the US district court for the district of Delaware relating to the Abbreviated New Drug Application (ANDA) filed by APP Pharmaceuticals, LLC (APP)...

PRINCETON, N.J. & WILMINGTON, Del. -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the...

Pharmacogenetic Patents Have the Potential to Extend Drug Candidate's Potential Commercial Exclusivity Period If Regulatory Approval Obtained BROOMFIELD, Colo. -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically targeted therapies for cardiovascular...

14 get a healthy start from Winthrop program Winthrop-University Hospital in Mineola took a step toward improving cardiovascular health in the community with the launch of BetterU, a 12-week fitness and lifestyle-improvement program....

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a40950/market_and_product) has announced the addition of the "Market and Product Forecasts: Antidyslipidemics - Set for the impact of generic Lipitor" report to their offering. The industry is bracing...

Standard Use of Rave by Japanese Specialty Pharma Across All Trials Will Streamline Research, Accelerate Decision Making and Help Expand Global Network NEW YORK & OSAKA, Japan -- Medidata Solutions (NASDAQ: MDSO), a...

EMERYVILLE, Calif. -- KineMed, Inc. (www.kinemed.com) announced today that co-founders Marc Hellerstein M.D., Ph.D., Chairman of the Scientific Advisory Board of KineMed and David Fineman, KineMed's CEO, will present at the 2012 Personalized...

HALLE, Germany -- Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the...

EWING, N.J. -- Antares Pharma, Inc. (NYSE Amex: AIS) today announced that it has licensed exclusively its Oxybutynin Gel 3% to Daewoong Pharmaceuticals Co. Ltd.,for marketing in South Korea. Antares will receive undisclosed...

NEW YORK -- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that reported earnings per share were $1.04 in the third quarter of fiscal 2012. Reported earnings per...

US BioDesign Expertise and Efficiency Significantly Reduces Delivery Timelines for Cardiovascular Biomaterials Clients PERKASIE, Pa. -- US BioDesign announced today the launch of its cardiovascular biomaterials business segment. This portion of US BioDesign...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/2458e4/myocardial_infarct) has announced the addition of GlobalData 's new report "Myocardial Infarction (MI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the industry...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/318c2f/france_pharmaceuti) has announced the addition of the "France Pharmaceuticals and Healthcare Report Q1 2012" report to their offering. Despite the government's focus on fiscal consolidation - which includes...

MIAMI BEACH, Fla. -- Nonstop nosebleeds can be serious and frightening, often sending people to the emergency room where their noses are packed with gauze. When that doesn't work, nosebleeds can be halted...

DUBLIN -- Research and Markets(http://www.researchandmarkets.com/research/db02ae/venous_thromboembo) has announced the addition of GlobalData 's new report "Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. GlobalData, the industry analysis...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/37c32e/analysis_of_cardio) has announced the addition of Frost & Sullivan's new report "Analysis of Cardiovascular Drugs Market in Saudi Arabia and the United Arab Emirates" to their offering. This...